Medical therapy of pericardial diseases Part II : Noninfectious pericarditis , pericardial effusion and constrictive pericarditis

The treatment of pericardial diseases is largely empirical because of the relative lack of randomized trials compared with other cardiovascular diseases. The main forms of pericardial diseases that can be encountered in the clinical setting include acute and recurrent pericarditis, pericardial effusion with or without cardiac tamponade, and constrictive pericarditis. Medical treatment should be targeted at the cause as much as possible. In this article, the therapy of more common forms of noninfectious pericarditis (pericarditis in systemic autoimmune diseases and neoplastic pericardial disease), pericardial effusion, and constrictive pericarditis is reviewed. J Cardiovasc Med 11:785–794 Q 2010 Italian Federation of Cardiology.

[1]  M. Refaat,et al.  Neoplastic Pericardial Effusion , 2011, Clinical cardiology.

[2]  Y. Adler,et al.  Diagnosis and management of pericardial diseases , 2009, Nature Reviews Cardiology.

[3]  Y. Adler,et al.  Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. , 2009, International journal of cardiology.

[4]  A. Buonadonna,et al.  Malignant pericardial effusion: sclerotherapy or local chemotherapy? , 2009, British Journal of Cancer.

[5]  R. Kwong,et al.  The Utility of Cardiovascular Magnetic Resonance in Constrictive Pericardial Disease , 2009, Cardiology in review.

[6]  Y. Adler,et al.  Aetiological diagnosis in acute and recurrent pericarditis: when and how , 2009, Journal of cardiovascular medicine.

[7]  N. Saijo,et al.  A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811) , 2009, British Journal of Cancer.

[8]  Y. Hosomi,et al.  [Treatment of malignant pericardial effusion]. , 2008, Gan to kagaku ryoho. Cancer & chemotherapy.

[9]  B. Mayosi Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa , 2007, Heart.

[10]  Y. Adler,et al.  Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. , 2007, The American journal of cardiology.

[11]  Q. Liang,et al.  Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis , 2007, Thorax.

[12]  L. Coda,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.

[13]  Marco Francone,et al.  Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy , 2006, European Radiology.

[14]  Y. Adler,et al.  Colchicine for recurrent acute pericarditis. , 2006, Archives of internal medicine.

[15]  S. Seth,et al.  Pericardiectomy for constrictive pericarditis: a clinical, echocardiographic, and hemodynamic evaluation of two surgical techniques. , 2006, The Annals of thoracic surgery.

[16]  Jin H. Lee,et al.  Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer. , 2005, Chest.

[17]  M. Imazio,et al.  Relation of acute pericardial disease to malignancy. , 2005, The American journal of cardiology.

[18]  C. Cipolla,et al.  Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa. , 2004, Chest.

[19]  M. Lauer,et al.  Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. , 2004, Journal of the American College of Cardiology.

[20]  E. W. Hancock,et al.  A clearer view of effusive-constrictive pericarditis. , 2004, The New England journal of medicine.

[21]  H. Schaff,et al.  Transient constrictive pericarditis: causes and natural history. , 2004, Journal of the American College of Cardiology.

[22]  D. Raoult,et al.  Etiologic Diagnosis of 204 Pericardial Effusions , 2003, Medicine.

[23]  A. Tajik,et al.  Constrictive Pericarditis in 26 Patients With Histologically Normal Pericardial Thickness , 2003, Circulation.

[24]  G. Patterson,et al.  Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion. , 2003, The Annals of thoracic surgery.

[25]  A. Ristic,et al.  Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin. , 2002, European heart journal.

[26]  C. Liau,et al.  Technical and prognostic outcomes of double-balloon pericardiotomy for large malignancy-related pericardial effusions. , 2002, Chest.

[27]  E. Viel,et al.  Local chemotherapy for neoplastic pericardial effusion. , 2000, The American journal of cardiology.

[28]  R. Perng,et al.  Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. , 2000, Chest.

[29]  J. Soler‐Soler,et al.  Clinical clues to the causes of large pericardial effusions. , 2000, The American journal of medicine.

[30]  J. Seward,et al.  Outcomes of primary and secondary treatment of pericardial effusion in patients with malignancy. , 2000, Mayo Clinic proceedings.

[31]  J. Soler‐Soler,et al.  Long-term follow-up of idiopathic chronic pericardial effusion. , 1999, The New England journal of medicine.

[32]  R. Siegel,et al.  Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s? , 1999, Chest.

[33]  J. Seward,et al.  Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. , 1999, Circulation.

[34]  K. Allen,et al.  Pericardial effusion: subxiphoid pericardiostomy versus percutaneous catheter drainage. , 1999, The Annals of thoracic surgery.

[35]  A. Goldhirsch,et al.  Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  E. Patz,et al.  Clinical Investigations: The PleuraSclerotherapy for Malignant Pleural Effusions: A Prospective Randomized Trial of Bleomycin vs Doxycycline with Small-Bore Catheter Drainage , 1998 .

[37]  A. Bayés‐Genís,et al.  Colchicine for large pericardial effusion , 1998, Clinical cardiology.

[38]  F. Shepherd,et al.  Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. , 1996, The Journal of thoracic and cardiovascular surgery.

[39]  W. Markiewicz,et al.  Intrapericardial minocycline sclerosis for malignant pericardial effusion. , 1996, Chest.

[40]  D. Baim,et al.  Pericardial effusion in patients with cancer: outcome with contemporary management strategies. , 1996, Heart.

[41]  R. Zayas,et al.  Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. , 1995, The American journal of cardiology.

[42]  C. O'connor,et al.  Etiology of large pericardial effusions. , 1993, The American journal of medicine.

[43]  W. Baumgartner,et al.  Current indications, risks, and outcome after pericardiectomy. , 1991, The Annals of thoracic surgery.

[44]  J. Soler‐Soler,et al.  Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. , 1987, The American journal of cardiology.

[45]  E. W. Hancock,et al.  The etiologic spectrum of constrictive pericarditis. , 1987, American heart journal.

[46]  J. Soler‐Soler,et al.  Primary acute pericardial disease: a prospective series of 231 consecutive patients. , 1985, The American journal of cardiology.

[47]  J. Małolepszy,et al.  [Metastases to the heart]. , 1966, Polski tygodnik lekarski.

[48]  A. Torbicki,et al.  Diagnostic utility of CYFRA 21-1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis. , 2005, The International journal of biological markers.

[49]  A. Fijałkowska,et al.  Evaluation of intrapericardial cisplatin administration in cases with recurrent malignant pericardial effusion and cardiac tamponade , 2004, Supportive Care in Cancer.

[50]  R. Urso,et al.  Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion , 2004, Cancer Chemotherapy and Pharmacology.

[51]  M. Metintaş,et al.  Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions. , 2001, Lung cancer.

[52]  D. Wilbur,et al.  Surgical management of pericardial effusion in patients with malignancies. Comparison of subxiphoid window versus pericardiectomy , 1991, Cancer.

[53]  R. J. Marvel Acute pericarditis. , 1956, The Journal of the Indiana State Medical Association.